Lamogin 5 mg contains Lamotrigine, an antiepileptic drug used for the management of epilepsy and bipolar disorder. It is primarily indicated for partial-onset seizures, generalized tonic-clonic seizures, and Lennox-Gastaut syndrome in adults and pediatric patients. Lamotrigine is also approved as a mood stabilizer for the maintenance treatment of bipolar disorder, particularly for the prevention of depressive episodes. Lamogin is valued for its efficacy, tolerability, and relatively low risk of sedation and cognitive impairment compared to other anticonvulsants.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Antiepileptic / Mood Stabilizer

Pharmacology

Lamotrigine works by inhibiting voltage-sensitive sodium channels, stabilizing neuronal membranes, and modulating the release of excitatory neurotransmitters such as glutamate and aspartate. This action helps prevent repetitive neuronal firing and reduces seizure activity.

Pharmacokinetic properties include:

• Rapid oral absorption, with peak plasma concentration occurring within 1–3 hours

• Bioavailability of approximately 98%

• Protein binding: ~55%

• Metabolism: Primarily hepatic via glucuronidation

• Elimination half-life: Approximately 25–33 hours in adults, shorter in children and longer when co-administered with valproate

• Excretion is mainly renal (glucuronide metabolites)

Lamotrigine has minimal sedative effects and a low risk of cognitive impairment, making it suitable for long-term therapy in both seizure management and mood stabilization.

Indications

Lamogin Tablet 5 mg is indicated for:

• Partial-onset seizures in adults and children

• Generalized tonic-clonic seizures

• Seizures associated with Lennox-Gastaut syndrome

• Maintenance therapy in bipolar disorder to prevent depressive episodes

Dosage and Administration

Adults (Seizures):

• Initial dose: 25 mg once daily for 2 weeks

• Gradually titrate every 1–2 weeks to a maintenance dose of 100–200 mg/day in divided doses

• Maximum recommended dose: 500 mg/day, depending on co-administration with other antiepileptics

Pediatric Patients (≥2 years):

• Dose depends on body weight and concomitant medications

• Start with 0.15–0.2 mg/kg/day and gradually titrate

Bipolar Disorder:

• Start at 25 mg daily, titrate gradually over 5–6 weeks

• Target maintenance dose: 200 mg/day (or 400 mg/day if co-administered with enzyme-inducing drugs)

Administration Notes:

• Tablets should be taken orally with or without food

• Do not discontinue abruptly, as this may precipitate seizures

• Gradual titration reduces the risk of severe skin reactions

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Contraindications

• Known hypersensitivity to lamotrigine or any excipients

• History of serious skin reactions to lamotrigine

Side Effects

Common side effects include:

• Dizziness, headache, and somnolence

• Nausea, vomiting, and gastrointestinal upset

• Rash (mild to moderate) – severe rash may indicate Stevens-Johnson syndrome or toxic epidermal necrolysis

• Ataxia, tremor, and blurred vision

• Rarely, hematologic abnormalities and liver dysfunction

Precautions and Warnings

• Skin reactions are more likely during initial titration or rapid dose escalation

• Use with caution in patients with hepatic or renal impairment

• Monitor for signs of suicidal ideation, especially in patients with mood disorders

Pregnancy and Lactation

• Lamotrigine is Pregnancy Category C

• Should be used during pregnancy only if clearly needed, with careful monitoring

• Lamotrigine is excreted in breast milk; caution is advised during breastfeeding

Storage Conditions

Store in a cool, dry place below 30°C, protected from light and moisture. Keep out of reach of children.

Mode of Action

Lamotrigine stabilizes neuronal membranes by selectively inhibiting sodium channels and reducing excitatory neurotransmitter release, thereby controlling seizures and preventing mood destabilization in bipolar disorder.